Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.

Brain research - 12 Jan 2006

Kanaan Nicholas M, Collier Timothy J, Marchionini Deanna M, McGuire Susan O, Fleming Matthew F, Sortwell Caryl E

Abstract excerpt

Parkinson's disease (PD) is a neurodegenerative disease marked by severe loss of dopamine (DA) neurons in the nigrostriatal system, which results in depletion of striatal DA. Transplantation of embryonic ventral mesencephalic (VM) DA neurons into the striatum is a currently explored experimental treatment aimed at replacing lost DA in the nigrostriatal system, but is plagued with poor survival (5-20%) of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Transplantation
Share to Erythropoietin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuroprotective Agents

Share to Oxidopamine

Share to Parkinson Disease, Secondary

Share to Perfusion

Share to Rats, Inbred F344

Share to Tyrosine 3-Monooxygenase

Source

Identifiers

PMID: 16368081
DOI: 10.1016/j.brainres.2005.10.078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.PMID 16368081Read ↗

Stem cell‐based therapy for Parkinson's diseaseSemantic proximity Read ↗

GRAFTS OF EMBRYONIC A9 DOPAMINE NEURONS IN A RAT ORGANOTYPIC CULTURE MODEL OF PARKINSON'S DISEASE INDICATES THE POTENTIAL AND LIMITS OF NIGRO-STRIATAL CIRCUITRY REFORMATIONSemantic proximity Read ↗

Human embryonic stem cells overexpressing dopaminergic transcription factors survive and differentiate in the substantia nigra in vivoSemantic proximity Read ↗

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's DiseaseSemantic proximity Read ↗

A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.Semantic proximity Read ↗

Cell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's disease.Semantic proximity Read ↗

Phenotypic development of the human embryonic striatal primordium: a study of cultured and grafted neurons from the lateral and medial ganglionic eminences.Semantic proximity Read ↗

Cell therapy and transplantation in Parkinson's disease.Semantic proximity Read ↗

Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos.Semantic proximity Read ↗

Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline.Semantic proximity Read ↗

Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's diseaseSemantic proximity Read ↗

Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.